Children's Hospital Association submitted comments on the cell and gene therapy request for information (RFI) from Sen. Bill Cassidy (R-La.), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee. Our response highlights the need to ensure children’s equitable access to these therapies and a strong national framework for payment and oversight.
CHA Response to Cell and Gene Therapy RFI
Cell and gene therapies have the potential to address unmet pediatric medical needs, reduce the need for costly chronic care, and help address health disparities.
Related Content
Pediatric Workforce Shortages Persist in 2024
Summary of Laboratory Developed Tests Final Rule
CHA Submits Energy and Commerce Committee Statement on Oversight of the 340B Drug Pricing Program
Pediatric Workforce Shortages Persist in 2024
Children’s hospitals continue to experience shortages across pediatric care fields with an outsized impact on mental and behavioral health specialties.
July 19, 2024
Summary of Laboratory Developed Tests Final Rule
Children's Hospital Association sent a letter to Energy and Commerce leaders supporting pediatric-focused legislation included in a recent markup.
July 17, 2024
CHA Submits Energy and Commerce Committee Statement on Oversight of the 340B Drug Pricing Program
Children's Hospital Association urges the committee to work with provider stakeholders to enhance the effectiveness and integrity of the program for children's health.
July 09, 2024
